Novo pushes back against obesity drug compounders as competition intensifies
Written by
BioPharma Dive
Published
0
comments
0
min
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucrative market for weight loss drugs.